Selskabets formål er at drive handel med farmaceutiske produkter, kemiske produkter, hospitalsprodukter og diagnostik samt udvikle, producere og markedsføre teknologi og know-how i forbindelse hermed. Selskabet kan derudover yde tjenesteydelser eller assistance, herunder af administrativ, driftsmæssig, finansiel, forretningsmæssig, videnskabelig eller industriel karakter, i tilknytning til Selskabets formål til tredjemænd, aktionærer, datterselskaber eller tilknyttede selskaber.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 350.4 mio. | 8.3 mio. | 262.6 mio. | 141.2 mio. | 49 | |
CVR: 31528615
Secondary names: MEDISENSE A/S, ABBOTT PRODUCTS A/S
Compared to 288 companies in Engroshandel med læge- og hospitalsartikler
Comparison is based on industry median values
Abbott Laboratories A/S demonstrates a solid financial health with consistent revenue growth over the past few years. In 2024, the company reported revenue of 350.4 million DKK and a profit of 8.3 million DKK, reflecting a positive trend from 327.4 million DKK in revenue and 9.2 million DKK in profit in 2023. Equity has also increased steadily, reaching 141.2 million DKK in 2024, indicating a strong capital position. However, profit margins have slightly declined, suggesting potential concerns regarding cost management. Overall, the company is well-positioned within the medical supplies industry, benefiting from a growing market demand.
AI-generated summary
Companies in the same industry and area
CVR 33671245
CVR 40041796
CVR 40549676
CVR 40557806
CVR 43707795
companydata.dk